| This CME Activity offers a practical review of breast pathology combining basic to advanced techniques, pearls and pitfalls to pathologic diagnosis and case reviews. |
Target AudienceÂ
| This CME activity is intended and designed to educate pathologists. |
AccreditationÂ
Physicians:Â Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Educational Symposia designates this enduring material for a maximum of 7.75Â AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.All activity participants are required to take a written or online test in order to be awarded credit. All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.AMA PRA Category 1 Credit(s)TMÂ for these programs may be claimed until December 31, 2021.
This CME activity was planned and produced by Educational Symposia, the leader in diagnostic imaging education since 1975.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.Topics
– Uses and Limitations of Immunohistochemistry in Breast Pathology
Stuart J. Schnitt, M.D.– Columnar Cell Lesions of the Breast
Phillip F.J. Tirman, M.D.– Molecular Classification of Breast Cancer: Where are we and Where are we going?
Stuart J. Schnitt, M.D.– Lumpectomy Margin Evaluation in the Contemporary Practice of Breast Pathology
Stuart J. Schnitt, M.D.– Papillary Lesions of the Breast
Laura C. Collins, M.D.– Core Needle Biopsy of the Breast: Striving for Fewer Excisions
Laura C. Collins, M.D.
Physicians:Â Educational Symposia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Educational Symposia designates this enduring material for a maximum of 7.75Â AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.All activity participants are required to take a written or online test in order to be awarded credit. All course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.AMA PRA Category 1 Credit(s)TMÂ for these programs may be claimed until December 31, 2021.
This CME activity was planned and produced by Educational Symposia, the leader in diagnostic imaging education since 1975.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.Topics
– Uses and Limitations of Immunohistochemistry in Breast Pathology
Stuart J. Schnitt, M.D.– Columnar Cell Lesions of the Breast
Phillip F.J. Tirman, M.D.– Molecular Classification of Breast Cancer: Where are we and Where are we going?
Stuart J. Schnitt, M.D.– Lumpectomy Margin Evaluation in the Contemporary Practice of Breast Pathology
Stuart J. Schnitt, M.D.– Papillary Lesions of the Breast
Laura C. Collins, M.D.– Core Needle Biopsy of the Breast: Striving for Fewer Excisions
Laura C. Collins, M.D.
– What’s New in Lumpectomy Margin Evaluation?
Stuart J. Schnitt, M.D.
– Lobular Carcinoma In Situ and Problematic In Situ Lesions of the Breast
Stuart J. Schnitt, M.D.
– Problematic Issues in Breast Core Needle Biopsies
Stuart J. Schnitt, M.D
CME Release Date 12/31/2019
CME Expiration Date 12/31/2021
